Literature DB >> 24798199

Hepatocellular carcinoma: have we finally found the ultimate staging system for HCC?

Julius Chapiro1, Jean-François Geschwind1.   

Abstract

A staging system capable of addressing the real issues facing patients with hepatocellular carcinoma has long been overdue. The new Hong Kong Liver Cancer staging system might do just that because it deals effectively with the limitations of previous staging systems.

Entities:  

Mesh：

Year:  2014        PMID： 24798199     DOI： 10.1038/nrgastro.2014.67

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  13 in total

1.  Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.

Authors:  Boris Gorodetski; Julius Chapiro; Ruediger Schernthaner; Rafael Duran; MingDe Lin; Howard Lee; David Lenis; Elizabeth A Stuart; Bareng Aletta Sanny Nonyane; Vasily Pekurovsky; Anobel Tamrazi; Bernhard Gebauer; Todd Schlachter; Timothy M Pawlik; Jean-Francois Geschwind
Journal:  Eur Radiol       Date:  2016-06-08       Impact factor: 5.315

Review 2.  New concepts in embolotherapy of HCC.

Authors:  F Pesapane; N Nezami; F Patella; J F Geschwind
Journal:  Med Oncol       Date:  2017-03-16       Impact factor: 3.064

3.  Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?

Authors:  Willie Magnus Luedemann; Dominik Geisel; Bernhard Gebauer; Dirk Schnapauff; Julius Chapiro; Gero Wieners; Ingo Steffen; Johannes Kahn
Journal:  Eur Radiol       Date:  2019-12-06       Impact factor: 5.315

4.  3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.

Authors:  Florian N Fleckenstein; Rüdiger E Schernthaner; Rafael Duran; Jae Ho Sohn; Sonia Sahu; Yan Zhao; Bernd Hamm; Bernhard Gebauer; MingDe Lin; Jean-François Geschwind; Julius Chapiro
Journal:  Eur Radiol       Date:  2016-01-13       Impact factor: 5.315

5.  A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.

Authors:  Shu-Yein Ho; Po-Hong Liu; Chia-Yang Hsu; Cheng-Yuan Hsia; Yi-Hsiang Huang; Chien-Wei Su; Hao-Jan Lei; Rheun-Chuan Lee; Ming-Chih Hou; Teh-Ia Huo
Journal:  Dig Dis Sci       Date:  2019-10-28       Impact factor: 3.199

Review 6.  Minimally invasive local therapies for liver cancer.

Authors:  David Li; Josephine Kang; Benjamin J Golas; Vincent W Yeung; David C Madoff
Journal:  Cancer Biol Med       Date:  2014-12       Impact factor: 4.248

7.  Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification.

Authors:  Kun Ke; Geng Chen; Zhixiong Cai; Yanbing Huang; Bixing Zhao; Yingchao Wang; Naishun Liao; Xiaolong Liu; Zhenli Li; Jingfeng Liu
Journal:  Cancer Manag Res       Date:  2018-11-05       Impact factor: 3.989

8.  Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.

Authors:  Yong-Fa Zhang; Ming Shi; Liang-He Lu; Lu Wang; Rong-Ping Guo
Journal:  J Hepatocell Carcinoma       Date:  2021-04-19

9.  Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology.

Authors:  Po-Hong Liu; Chia-Yang Hsu; Yun-Hsuan Lee; Chien-Wei Su; Cheng-Yuan Hsia; Yi-Hsiang Huang; Yi-You Chiou; Han-Chieh Lin; Teh-Ia Huo
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

10.  The serum metabolic profiles of different Barcelona stages hepatocellular carcinoma associated with hepatitis B virus.

Authors:  Lei Zhang; Guang-Ye Wu; Yu-Jing Wu; Shu-Ye Liu
Journal:  Oncol Lett       Date:  2017-11-13       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.